GH
NASDAQ
$148.07
Guardant Health Inc (GH)
Guardant Health, Inc., a precision oncology company, offers blood testing, data sets, and testing in the United States and internationally. The company is headquartered in Redwood City, California.
Sector:
Healthcare
Industry:
Diagnostics & Research
Buy
Target: $171.08 (+15.54%)
Market Cap
$21B
Revenue 5Y CAGR
+29.39%
Free Cash Flow Yield
-1.11%
Beta (5Y)
1.17
Price Chart
Valuation
Market Cap$21B
P/S20.00
P/B55.67
Profitability
Total Revenue (TTM)$1.08B
Gross Profit (TTM)$701M
EBITDA-$409M
Profit Margin-37.1%
Operating Margin-40.2%
EPS-$3.38
Financial Health
Debt-to-Equity-830.3%
Free Cash Flow Yield-1.11%
Growth & Risk
EPS 5Y CAGR+1.05%
Revenue 5Y CAGR+29.39%
FCF 5Y CAGR+10.63%
Beta (5Y)1.17
Sharpe Ratio2.11